Could anticipatory deprescribing allow better COVID treatment? Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.
Studies focus on COVID infectious period Early research suggests a quarter of people or more may still be infectious with COVID-19 after seven days, the standard isolation period across Australia.
How can asthma medication overprescribing be reduced? Study suggests many patients may be prescribed ‘higher than necessary’ doses to control their asthma, increasing the risk of side effects.
Push to assess COVID-19 treatment eligibility prior to infection College launches new guidelines to support GPs assessing the best approach for vulnerable patients before they test positive.
What doctors think about antidepressants and the ‘serotonin theory’ Two GPs and two psychiatrists provide reactions from the mental health coalface to a new systematic umbrella review that questions the role ‘chemical imbalance’ plays in depression.
‘Not sustainable’: Medicine shortages in focus The Government is being urged to shore up pharmaceutical supply chains to avoid ‘problematic’ disruptions to patient care.
RACFs prescribing changes ‘an important step forward’ Adoption of electronic medication charts in residential aged care facilities could be ‘a game changer’ for GPs who provide aged care.
Monkeypox now a disease of ‘national significance’ The declaration was made by Australia’s CMO, while ATAGI has also released updated guidance on vaccination.
COVID vaccine safety data for children ‘extremely reassuring’ A new study tracking nearly 400,000 children aged 5–15 post-vaccination found adverse events were generally short-term and mild.
Almost one in every two Australians has had COVID-19 Survey taken from blood donors in June confirms that levels have increased exponentially since a similar study in March.